Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H28N2O2.2ClH |
| Molecular Weight | 425.392 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=ZYTHLJLPPSSDIP-UHFFFAOYSA-N
InChI=1S/C22H28N2O2.2ClH/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;;/h3-11H,2,12-17,23H2,1H3;2*1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C22H28N2O2 |
| Molecular Weight | 352.4699 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/13815278
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13815278
Aniledrine is a narcotic pain reliver. The drug was prescribed as an analgesic in anaesthesia (Leritine brand name), however, it is no longer available on the market. Although the exact mechanism is not fully understood, aniledrine appears to elicit its action by binding to endorphine receptors in CNS.
CNS Activity
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13815278 |
Curative | LERITINE Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis, characterization and antimicrobial properties of a Co(II)-phthalylsulfathiazolate complex. | 2010-12 |
|
| Metabolic fate of orally administered phyllodulcin in rats. | 2004-09 |
|
| Electronic-topological study of the structure-activity relationships in a series of piperidine morphinomimetics. | 2002-08 |
|
| Anileridine-induced delirium. | 1995-05 |
|
| Qualitative differences in effects of opioids in man: preliminary evidence for multiple mechanisms of analgesic action. | 1986-05 |
|
| Contact dermatitis to anileridine. | 1980-12 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:22 GMT 2025
by
admin
on
Mon Mar 31 17:45:22 GMT 2025
|
| Record UNII |
915Q054DLC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1506
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
915Q054DLC
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
204-770-0
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201347
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
C100232
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
31338
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
SUB36186
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
Anileridine hydrochloride
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
235413
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000128735
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
C65235
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
61208
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
DTXSID50155034
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
SUB00532MIG
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
DBSALT001408
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | |||
|
m1921
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY | Merck Index | ||
|
126-12-5
Created by
admin on Mon Mar 31 17:45:22 GMT 2025 , Edited by admin on Mon Mar 31 17:45:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |